Business Description
Teva Pharmaceutical Industries Ltd
NAICS : 325412
ISIN : IL0006290147
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.12 | |||||
Equity-to-Asset | 0.15 | |||||
Debt-to-Equity | 2.98 | |||||
Debt-to-EBITDA | 9.92 | |||||
Interest Coverage | 3.49 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 0.29 | |||||
Beneish M-Score | -2.35 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -2.4 | |||||
3-Year EPS without NRI Growth Rate | -0.1 | |||||
3-Year FCF Growth Rate | 8.9 | |||||
3-Year Book Growth Rate | -9.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 5.71 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 3.18 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 70.14 | |||||
9-Day RSI | 64.8 | |||||
14-Day RSI | 60.68 | |||||
6-1 Month Momentum % | 25.74 | |||||
12-1 Month Momentum % | 98.53 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.89 | |||||
Quick Ratio | 0.59 | |||||
Cash Ratio | 0.17 | |||||
Days Inventory | 177.93 | |||||
Days Sales Outstanding | 78.66 | |||||
Days Payable | 108.18 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.7 | |||||
Shareholder Yield % | 7.07 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 49.48 | |||||
Operating Margin % | 21.27 | |||||
Net Margin % | -2.92 | |||||
FCF Margin % | 4.17 | |||||
ROE % | -6.78 | |||||
ROA % | -1.12 | |||||
ROIC % | 42.8 | |||||
3-Year ROIIC % | -2.31 | |||||
ROC (Joel Greenblatt) % | 13.68 | |||||
ROCE % | 2.75 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 6.65 | |||||
PE Ratio without NRI | 6.91 | |||||
PS Ratio | 1.28 | |||||
PB Ratio | 3.29 | |||||
Price-to-Free-Cash-Flow | 30.51 | |||||
Price-to-Operating-Cash-Flow | 17.73 | |||||
EV-to-EBIT | 45.79 | |||||
EV-to-Forward-EBIT | 14.75 | |||||
EV-to-EBITDA | 19.86 | |||||
EV-to-Forward-EBITDA | 10.52 | |||||
EV-to-Revenue | 2.32 | |||||
EV-to-Forward-Revenue | 2.24 | |||||
EV-to-FCF | 55.48 | |||||
Price-to-Projected-FCF | 2.1 | |||||
Price-to-Median-PS-Value | 1.67 | |||||
Earnings Yield (Greenblatt) % | 2.18 | |||||
FCF Yield % | 3.22 | |||||
Forward Rate of Return (Yacktman) % | 13.42 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Teva Pharmaceutical Industries Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₪) | 60,302.811 | ||
EPS (TTM) (₪) | -1.443 | ||
Beta | 0 | ||
Volatility % | 26.99 | ||
14-Day RSI | 60.68 | ||
14-Day ATR (₪) | 1.225147 | ||
20-Day SMA (₪) | 66.812 | ||
12-1 Month Momentum % | 98.53 | ||
52-Week Range (₪) | 32.82 - 70.57 | ||
Shares Outstanding (Mil) | 1,132.91 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Teva Pharmaceutical Industries Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Teva Pharmaceutical Industries Ltd Stock Events
Event | Date | Price(₪) | ||
---|---|---|---|---|
No Event Data |
Teva Pharmaceutical Industries Ltd Frequently Asked Questions
What is Teva Pharmaceutical Industries Ltd(XTAE:TEVA)'s stock price today?
When is next earnings date of Teva Pharmaceutical Industries Ltd(XTAE:TEVA)?
Does Teva Pharmaceutical Industries Ltd(XTAE:TEVA) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |